Adaptimmune Therapeutics Plc (ADAPY)
0.003
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Adaptimmune Therapeutics SG&A Expense (TTM) : 90.50M for June 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Silence Therapeutics Plc | 22.34M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| Oxford Biomedica Plc | 48.35M |
| NuCana Plc | 10.74M |
| Autolus Therapeutics Plc | 131.95M |